I get your point. The report generated by XVLVAS or CTLVAS is the interpretation of the data acquired in the scanning process. It’s not a ‘scan’ as we typically know them.
Much of 4Dmedical’s work has been comparative with the accepted gold standards, validating the utility of the invention. I think it’s pretty much accepted now that the products work. That is why I’m tiring of excuses for lack of revenue. Yes clinicians are reluctant adopters. Yes Philips works at its own pace. These are not valid reasons for commercial inaction.
4DX Price at posting:
30.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)